vs

Side-by-side financial comparison of RHYTHM PHARMACEUTICALS, INC. (RYTM) and Latham Group, Inc. (SWIM). Click either name above to swap in a different company.

Latham Group, Inc. is the larger business by last-quarter revenue ($100.0M vs $57.3M, roughly 1.7× RHYTHM PHARMACEUTICALS, INC.). Latham Group, Inc. runs the higher net margin — -7.0% vs -83.0%, a 76.0% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs 14.5%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs -4.9%).

Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.

Latham & Watkins LLP is an American multinational law firm. Founded in 1934 in Los Angeles, California, it is known for its litigation, corporate, and regulatory law practices.

RYTM vs SWIM — Head-to-Head

Bigger by revenue
SWIM
SWIM
1.7× larger
SWIM
$100.0M
$57.3M
RYTM
Growing faster (revenue YoY)
RYTM
RYTM
+22.3% gap
RYTM
36.9%
14.5%
SWIM
Higher net margin
SWIM
SWIM
76.0% more per $
SWIM
-7.0%
-83.0%
RYTM
Faster 2-yr revenue CAGR
RYTM
RYTM
Annualised
RYTM
48.5%
-4.9%
SWIM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
RYTM
RYTM
SWIM
SWIM
Revenue
$57.3M
$100.0M
Net Profit
$-47.5M
$-7.0M
Gross Margin
91.6%
28.0%
Operating Margin
-82.2%
-10.7%
Net Margin
-83.0%
-7.0%
Revenue YoY
36.9%
14.5%
Net Profit YoY
-9.6%
76.0%
EPS (diluted)
$-0.73
$-0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RYTM
RYTM
SWIM
SWIM
Q4 25
$57.3M
$100.0M
Q3 25
$51.3M
$161.9M
Q2 25
$48.5M
$172.6M
Q1 25
$32.7M
$111.4M
Q4 24
$41.8M
$87.3M
Q3 24
$33.3M
$150.5M
Q2 24
$29.1M
$160.1M
Q1 24
$26.0M
$110.6M
Net Profit
RYTM
RYTM
SWIM
SWIM
Q4 25
$-47.5M
$-7.0M
Q3 25
$-52.9M
$8.1M
Q2 25
$-46.6M
$16.0M
Q1 25
$-49.5M
$-6.0M
Q4 24
$-43.3M
$-29.2M
Q3 24
$-43.6M
$5.9M
Q2 24
$-32.3M
$13.3M
Q1 24
$-141.4M
$-7.9M
Gross Margin
RYTM
RYTM
SWIM
SWIM
Q4 25
91.6%
28.0%
Q3 25
89.3%
35.4%
Q2 25
88.6%
37.1%
Q1 25
88.8%
29.5%
Q4 24
90.9%
24.6%
Q3 24
88.5%
32.4%
Q2 24
89.9%
33.1%
Q1 24
89.2%
27.7%
Operating Margin
RYTM
RYTM
SWIM
SWIM
Q4 25
-82.2%
-10.7%
Q3 25
-102.6%
13.3%
Q2 25
-93.4%
14.3%
Q1 25
-143.7%
-4.4%
Q4 24
-98.6%
-14.9%
Q3 24
-132.0%
8.9%
Q2 24
-139.2%
12.5%
Q1 24
-538.7%
-1.9%
Net Margin
RYTM
RYTM
SWIM
SWIM
Q4 25
-83.0%
-7.0%
Q3 25
-103.1%
5.0%
Q2 25
-96.1%
9.3%
Q1 25
-151.4%
-5.4%
Q4 24
-103.6%
-33.4%
Q3 24
-131.2%
3.9%
Q2 24
-110.9%
8.3%
Q1 24
-544.4%
-7.1%
EPS (diluted)
RYTM
RYTM
SWIM
SWIM
Q4 25
$-0.73
$-0.06
Q3 25
$-0.82
$0.07
Q2 25
$-0.75
$0.13
Q1 25
$-0.81
$-0.05
Q4 24
$-0.71
$-0.24
Q3 24
$-0.73
$0.05
Q2 24
$-0.55
$0.11
Q1 24
$-2.35
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RYTM
RYTM
SWIM
SWIM
Cash + ST InvestmentsLiquidity on hand
$388.9M
Total DebtLower is stronger
$279.8M
Stockholders' EquityBook value
$139.1M
$405.9M
Total Assets
$480.2M
$823.2M
Debt / EquityLower = less leverage
0.69×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RYTM
RYTM
SWIM
SWIM
Q4 25
$388.9M
Q3 25
$416.1M
Q2 25
$291.0M
Q1 25
$314.5M
Q4 24
$320.6M
Q3 24
$298.4M
Q2 24
$319.1M
Q1 24
$201.2M
Total Debt
RYTM
RYTM
SWIM
SWIM
Q4 25
$279.8M
Q3 25
$281.1M
Q2 25
$281.5M
Q1 25
$306.9M
Q4 24
$281.5M
Q3 24
$282.8M
Q2 24
$282.4M
Q1 24
$282.8M
Stockholders' Equity
RYTM
RYTM
SWIM
SWIM
Q4 25
$139.1M
$405.9M
Q3 25
$148.8M
$408.4M
Q2 25
$-11.9M
$398.4M
Q1 25
$18.9M
$381.1M
Q4 24
$21.7M
$387.2M
Q3 24
$11.2M
$416.6M
Q2 24
$39.3M
$408.1M
Q1 24
$61.6M
$391.8M
Total Assets
RYTM
RYTM
SWIM
SWIM
Q4 25
$480.2M
$823.2M
Q3 25
$506.9M
$844.4M
Q2 25
$372.7M
$822.1M
Q1 25
$386.7M
$824.6M
Q4 24
$392.3M
$794.2M
Q3 24
$363.6M
$853.4M
Q2 24
$381.8M
$830.0M
Q1 24
$258.7M
$808.6M
Debt / Equity
RYTM
RYTM
SWIM
SWIM
Q4 25
0.69×
Q3 25
0.69×
Q2 25
0.71×
Q1 25
0.81×
Q4 24
0.73×
Q3 24
0.68×
Q2 24
0.69×
Q1 24
0.72×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RYTM
RYTM
SWIM
SWIM
Operating Cash FlowLast quarter
$-25.4M
$23.3M
Free Cash FlowOCF − Capex
$14.1M
FCF MarginFCF / Revenue
14.1%
Capex IntensityCapex / Revenue
9.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$38.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RYTM
RYTM
SWIM
SWIM
Q4 25
$-25.4M
$23.3M
Q3 25
$-26.6M
$51.0M
Q2 25
$-23.3M
$36.0M
Q1 25
$-40.4M
$-46.9M
Q4 24
$-18.8M
$6.2M
Q3 24
$-25.2M
$37.2M
Q2 24
$-29.1M
$52.4M
Q1 24
$-40.7M
$-34.5M
Free Cash Flow
RYTM
RYTM
SWIM
SWIM
Q4 25
$14.1M
Q3 25
$45.2M
Q2 25
$29.1M
Q1 25
$-50.3M
Q4 24
$-98.0K
Q3 24
$33.2M
Q2 24
$47.9M
Q1 24
$-39.9M
FCF Margin
RYTM
RYTM
SWIM
SWIM
Q4 25
14.1%
Q3 25
27.9%
Q2 25
16.8%
Q1 25
-45.2%
Q4 24
-0.1%
Q3 24
22.1%
Q2 24
29.9%
Q1 24
-36.0%
Capex Intensity
RYTM
RYTM
SWIM
SWIM
Q4 25
9.2%
Q3 25
3.6%
Q2 25
4.0%
Q1 25
3.1%
Q4 24
7.2%
Q3 24
2.7%
Q2 24
2.8%
Q1 24
4.8%
Cash Conversion
RYTM
RYTM
SWIM
SWIM
Q4 25
Q3 25
6.29×
Q2 25
2.25×
Q1 25
Q4 24
Q3 24
6.32×
Q2 24
3.95×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RYTM
RYTM

Segment breakdown not available.

SWIM
SWIM

In Ground Swimming Pools$50.2M50%
Covers$37.0M37%
Liners$12.7M13%

Related Comparisons